MiR-326/Sp1/KLF3: A Novel Regulatory Axis in Lung Cancer Progression
Rong Wang,Jiali Xu,Jing Xu,Wei Zhu,Tianzhu Qiu,Jun Li,Meiling Zhang,Qianqian Wang,Tongpeng Xu,Renhua Guo,Kaihua Lu,Yongmei Yin,Yanhong Gu,Lingjun Zhu,Puwen Huang,Ping Liu,Lianke Liu,Wei De,Yongqian Shu
DOI: https://doi.org/10.1111/cpr.12551
IF: 8.755
2018-01-01
Cell Proliferation
Abstract:Objectives To investigate the function and regulatory mechanism of Kruppel-like factor 3 (KLF3) in lung cancer. Materials and Methods KLF3 expression was analysed by qRT-PCR and Western blot assays. The proliferation, migration, invasion, cycle and apoptosis were measured by CCK-8 and EdU, wound-healing and Transwell, and flow cytometry assays. The tumour growth was detected by nude mouse tumorigenesis assay. In addition, the interaction between KLF3 and Sp1 was accessed by luciferase reporter, EMSA and ChIP assay. JAK2, STAT3, PI3K and p-AKT levels were evaluated by Western blot and IHC assays. Results The results indicated that KLF3 expression was elevated in lung cancer tissues. Knockdown of KLF3 inhibited lung cancer cell proliferation, migration and invasion, and induced cell cycle arrest and apoptosis. In addition, the downregulation of KLF3 suppressed tumour growth in vivo. KLF3 was transcriptionally activated by Sp1. miR-326 could bind to 3 ' UTR of Sp1 but not KLF3 and decreased the accumulation of Sp1, which further indirectly reduced KLF3 expression and inactivated JAK2/STAT3 and PI3K/AKT signaling pathways in vitro and in vivo. Conclusions Our data demonstrate that miR-326/Sp1/KLF3 regulatory axis is involved in the development of lung cancer, which hints the potential target for the further therapeutic strategy against lung cancer.